GWOCS Algorithm for EEG-Based Dementia Subtype Classification

The GWOCS (Gaussian Weighted Coherent Set Selection) algorithm is a machine learning approach designed to classify dementia subtypes using electroencephalography (EEG) signals. By employing SHAP (SHapley Additive exPlanations) interpretability, the method identifies discriminative features from prefrontal and temporal brain regions that distinguish between Alzheimer's disease (AD), dementia with Lewy bodies (DLB), frontotemporal dementia (FTD), and vascular dementia (VaD).

Overview

Differential diagnosis of dementia subtypes remains clinically challenging due to overlapping symptom profiles. EEG-based machine learning offers a non-invasive, cost-effective approach to identify neurophysiological signatures unique to each subtype. The GWOCS algorithm addresses this by:

• Selecting coherent EEG feature sets from specific brain regions
• Applying Gaussian weighting to emphasize temporally consistent patterns
• Using SHAP values for clinical interpretability
• Differentiating subtypes through region-specific biomarkers

Methodology

Feature Extraction Pipeline

```mermaid
graph TD
A["Raw EEG Data"] --> B["Preprocessing"]
B --> C["Artifact Removal"]
C --> D["Spectral Analysis"]
D --> E["Feature Extraction"]
E --> F["GWOCS Selection"]
F --> G["SHAP Interpretation"]
G --> H["Classification"]

D --> D1["Power Spectral Density"]
D --> D2["Coherence Analysis"]
D --> D3["Connectivity Metrics"]

E --> E1["Delta 0.5-4 Hz"]
E --> E2["Theta 4-8 Hz"]
E --> E3["Alpha 8-13 Hz"]
E --> E4["Beta 13-30 Hz"]

...

The GWOCS (Gaussian Weighted Coherent Set Selection) algorithm is a machine learning approach designed to classify dementia subtypes using electroencephalography (EEG) signals. By employing SHAP (SHapley Additive exPlanations) interpretability, the method identifies discriminative features from prefrontal and temporal brain regions that distinguish between Alzheimer's disease (AD), dementia with Lewy bodies (DLB), frontotemporal dementia (FTD), and vascular dementia (VaD).

Overview

Differential diagnosis of dementia subtypes remains clinically challenging due to overlapping symptom profiles. EEG-based machine learning offers a non-invasive, cost-effective approach to identify neurophysiological signatures unique to each subtype. The GWOCS algorithm addresses this by:

• Selecting coherent EEG feature sets from specific brain regions
• Applying Gaussian weighting to emphasize temporally consistent patterns
• Using SHAP values for clinical interpretability
• Differentiating subtypes through region-specific biomarkers

Methodology

Feature Extraction Pipeline

The GWOCS algorithm extracts features from prefrontal (Fp1, Fp2, FpZ) and temporal (T3, T4, T5, T6) electrode positions, as these regions show distinct alteration patterns across dementia subtypes.

Gaussian Weighted Coherent Set Selection

The core innovation of GWOCS lies in its feature selection mechanism:

Coherence calculation: Compute inter-electrode coherence for all electrode pairs within the prefrontal and temporal regions

Temporal stability assessment: Evaluate coherence consistency across multiple time windows

Gaussian weighting: Apply a Gaussian kernel to weight features based on:

• Temporal consistency (longer stable coherence = higher weight)
• Frequency-specific importance (delta/theta for temporal regions, alpha for prefrontal)
• Inter-hemispheric symmetry (asymmetric patterns weighted higher)

4. Set selection: Choose the highest-weighted coherent feature sets for classification

Classification Architecture

Brain Regions and Their Diagnostic Value

Prefrontal Cortex

The prefrontal region (Fp1, Fp2, FpZ) provides critical markers for:

| Feature | AD Pattern | DLB Pattern | FTD Pattern |
|---------|-----------|-------------|-------------|
| Alpha power | Reduced | Severely reduced | Preserved |
| Theta power | Increased | Variable | Variable |
| Coherence | Decreased | Abnormal | Variable |

Prefrontal EEG alterations reflect executive dysfunction and attentional deficits common in multiple dementia types, but the specific pattern of frequency changes helps differentiate them. [@d中超2022]

Temporal Regions

Temporal electrodes (T3, T4, T5, T6) capture:

| Feature | AD Pattern | DLB Pattern | FTD Pattern |
|---------|-----------|-------------|-------------|
| Delta/Theta | Increased | Variable | Prominent slowing |
| Alpha | Posterior dominance lost | Reduced | Variable |
| Coherence | Decreased | Abnormal | Decreased |

Temporal lobe dysfunction is most pronounced in AD, where hippocampal atrophy manifests as posterior temporal alpha slowing. [@stam2009] FTD shows anterior temporal patterns, while DLB exhibits characteristic posterior alpha reduction. [@babiloni2020]

SHAP Interpretability

The GWOCS algorithm uses SHAP (SHapley Additive exPlanations) values to provide clinical interpretability:

Feature Importance Ranking

Prefrontal alpha coherence: Most discriminative for DLB vs. AD

Temporal theta power: Strongest marker for AD progression

Inter-hemispheric asymmetry: Distinguishes FTD from AD

Delta/theta ratio: Differentiates VaD from other subtypes

Clinical Explanation Generation

SHAP values generate patient-specific explanations:

Example SHAP explanation structure

{
"patient_id": "P001",
"prediction": "Dementia with Lewy Bodies",
"confidence": 0.87,
"top_features": [
{"feature": "Fp2_alpha_coherence", "shap_value": 0.34, "direction": "negative"},
{"feature": "T6_theta_power", "shap_value": 0.28, "direction": "positive"},
{"feature": "Fp1_delta_coherence", "shap_value": 0.21, "direction": "negative"}
],
"clinical_explanation": "Reduced prefrontal alpha coherence and elevated temporal theta power support DLB diagnosis"
}

This interpretability enables clinicians to:

• Understand model predictions
• Validate against clinical judgment
• Identify regions requiring further investigation
• Track biomarker changes over time

Accuracy Metrics

GWOCS demonstrates high classification performance:

| Comparison | Accuracy | Sensitivity | Specificity | AUC |
|------------|----------|-------------|-------------|-----|
| AD vs. Normal | 94.2% | 92.8% | 95.6% | 0.97 |
| AD vs. DLB | 89.7% | 88.1% | 91.3% | 0.94 |
| AD vs. FTD | 87.3% | 85.4% | 89.2% | 0.91 |
| DLB vs. FTD | 85.1% | 82.7% | 87.5% | 0.89 |
| Multi-class (4 types) | 83.6% | 81.2% | 94.1% | 0.92 |

[@gwon2023] These results exceed traditional EEG-based approaches and compare favorably to more invasive biomarkers.

Clinical Utility

Diagnostic Workflow Integration

Advantages

Non-invasive: Uses standard EEG, no contrast agents or radiation

Cost-effective: Less expensive than PET or CSF biomarkers

Rapid: Analysis completes in minutes

Repeatable: Suitable for disease progression monitoring

Interpretable: SHAP explanations align with clinical reasoning

Limitations

Mild cognitive impairment overlap: Early-stage features may be subtle

Medication effects: Anticholinergic and sedative medications alter EEG

Technical requirements: Requires standardized acquisition protocols

Population specificity: Training data demographics affect generalizability

Related Technologies

• [EEG Biomarkers for Alzheimer's Disease](/biomarkers/eeg-biomarkers-alzheimers)
• [Electroencephalography in Neurodegeneration](/diagnostics/electroencephalography)
• [Machine Learning in Neurodegeneration](/mechanisms/ai-machine-learning-neurodegeneration)
• [BCI for Dementia Monitoring](/technologies/bci-alzheimers-disease)
• [BCI for Frontotemporal Dementia](/technologies/bci-frontotemporal-dementia)
• [BCI for Lewy Body Dementia](/technologies/bci-lewy-body-dementia)

References

[Gwon et al., Weighted Coherent Set Selection (GWOCS) for EEG-based dementia classification (2023)](https://doi.org/10.1016/j.neunet.2023.02.012)

[Chen et al., SHAP-based interpretability in neurological disease classification (2022)](https://doi.org/10.1109/TNNLS.2022.3168901)

[Stam et al., EEG coherence in Alzheimer's disease and dementia with Lewy bodies (2009)](https://pubmed.ncbi.nlm.nih.gov/19328867/)

[Babiloni et al., Quantitative EEG markers in dementia (2020)](https://doi.org/10.1016/j.neubiorev.2020.09.020)

[Cassani et al., EEG spectral alterations in Alzheimer's disease detection (2018)](https://pubmed.ncbi.nlm.nih.gov/30122243/)

[Zhang et al., Prefrontal EEG features in frontotemporal dementia (2022)](https://doi.org/10.1016/j.clinph.2022.01.008)

[Forsberg et al., EEG frequency analysis in dementia subtypes (2016)](https://doi.org/10.1111/joa.12456)

[Hernández et al., Temporal EEG patterns for dementia differentiation (2019)](https://doi.org/10.1016/j.neulet.2019.134678)

[Song et al., Machine learning with EEG for Alzheimer's disease classification (2018)](https://doi.org/10.1016/j.neunet.2018.07.012)

[Al-Nuaimi et al., EEG features for dementia subtypes classification (2020)](https://doi.org/10.1002/cem.3234)